Galera Therapeutics
IPOTransforming the science and treatment of cancer.
- Headquarters
- Malvern
- Employees
- 1–10
- Founded
- 2009
- Business Model
- B2B
- Website
- galeratx.com
- Total Funding
- $203.0M
- Last Round
- $150.0M Series CSep 2018
- Rounds
- 3
- Type
- Public
About
Galera Therapeutics is a clinical-stage biopharmaceutical company pioneering novel small molecules that target critical vulnerabilities in cancer cells, immune cells, and the tumor microenvironment. Based in Malvern, Pennsylvania, Galera focuses on improving the anti-cancer efficacy of current therapies, particularly for patients with breast cancer.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...